Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase
- PMID: 12816949
- DOI: 10.1074/jbc.M212733200
Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase
Abstract
The dihydrolipoyl acetyltransferase (E2) has an enormous impact on pyruvate dehydrogenase kinase (PDK) phosphorylation of the pyruvate dehydrogenase (E1) component by acting as a mobile binding framework and in facilitating and mediating regulation of PDK activity. Analytical ultracentrifugation (AUC) studies established that the soluble PDK2 isoform is a stable dimer. The interaction of PDK2 with the lipoyl domains of E2 (L1, L2) and the E3-binding protein (L3) were characterized by AUC. PDK2 interacted very weakly with L2 (Kd approximately 175 microM for 2 L2/PDK2) but much tighter with dimeric glutathione S-transferase (GST)-L2 (Kd approximately 3 microM), supporting the importance of bifunctional binding. Reduction of lipoyl groups resulted in approximately 8-fold tighter binding of PDK2 to GST-L2red, which was approximately 300-fold tighter than binding of 2 L2red and also much tighter than binding by GST-L1red and GST-L3red. The E2 60-mer bound approximately 18 PDK2 dimers with a Kd similar to GST-L2. E2.E1 bound more PDK2 (approximately 27.6) than E2 with approximately 2-fold tighter affinity. Lipoate reduction fostered somewhat tighter binding at more sites by E2 and severalfold tighter binding at the majority of sites on E2.E1. ATP and ADP decreased the affinity of PDK2 for E2 by 3-5-fold and adenosine 5'-(beta,gamma-imino)triphosphate or phosphorylation of E1 similarly reduced PDK2 binding to E2.E1. Reversible bifunctional binding to L2 with the mandatory singly held transition fits the proposed "hand-over-hand" movement of a kinase dimer to access E1 without dissociating from the complex. The gain in binding interactions upon lipoate reduction likely aids reduction-engendered stimulation of PDK2 activity; loosening of binding as a result of adenine nucleotides and phosphorylation may instigate movement of lipoyl domain-held kinase to a new E1 substrate.
Similar articles
-
Marked differences between two isoforms of human pyruvate dehydrogenase kinase.J Biol Chem. 2000 May 26;275(21):15773-81. doi: 10.1074/jbc.M909488199. J Biol Chem. 2000. PMID: 10748134
-
Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.Biochemistry. 2004 Oct 26;43(42):13432-41. doi: 10.1021/bi049488x. Biochemistry. 2004. PMID: 15491150
-
Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP.Biochemistry. 2004 Oct 26;43(42):13442-51. doi: 10.1021/bi0494875. Biochemistry. 2004. PMID: 15491151
-
Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.Cell Mol Life Sci. 2007 Apr;64(7-8):830-49. doi: 10.1007/s00018-007-6380-z. Cell Mol Life Sci. 2007. PMID: 17310282 Free PMC article. Review.
-
Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases.Exp Mol Med. 2001 Dec 31;33(4):191-7. doi: 10.1038/emm.2001.32. Exp Mol Med. 2001. PMID: 11795479 Review.
Cited by
-
Structural and functional insights into the molecular mechanisms responsible for the regulation of pyruvate dehydrogenase kinase 2.J Biol Chem. 2008 Jun 6;283(23):15789-98. doi: 10.1074/jbc.M800311200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18387944 Free PMC article.
-
Global view of cognate kinase activation by the human pyruvate dehydrogenase complex.Sci Rep. 2017 Feb 23;7:42760. doi: 10.1038/srep42760. Sci Rep. 2017. PMID: 28230160 Free PMC article.
-
The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity.Biochemistry. 2005 Oct 18;44(41):13573-82. doi: 10.1021/bi0505868. Biochemistry. 2005. PMID: 16216081 Free PMC article.
-
Recognition of the inner lipoyl-bearing domain of dihydrolipoyl transacetylase and of the blood glucose-lowering compound AZD7545 by pyruvate dehydrogenase kinase 2.Biochemistry. 2007 Jul 24;46(29):8592-602. doi: 10.1021/bi700650k. Epub 2007 Jun 30. Biochemistry. 2007. PMID: 17602666 Free PMC article.
-
Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.EMBO J. 2005 May 18;24(10):1763-74. doi: 10.1038/sj.emboj.7600663. Epub 2005 Apr 28. EMBO J. 2005. PMID: 15861126 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous